小鼠局灶性脑缺血梗死灶的定量分析

目的:用小鼠持续性局灶性脑缺血模型, 证明新建的透光法测定局灶性脑缺血梗死灶的实用性。方法:采用大脑中动脉阻塞法(MCAO) 造成小鼠持续性局灶性脑缺血, 于缺血后24 h 进行Bederson's症状评分和爬板、悬挂试验, 并以计算机图像分析技术测定和分析脑缺血梗死体积、脑半球面积、皮层及皮层下神经元密度;在大脑中动脉线栓手术前3 d和术前1 h 分别腹腔注射Pranlukast 0.1 mg°kg^-1 或尼莫地平0.4 mg°kg^-1, 观察药物的神经保护作用。结果:透光测定的梗死体积与TTC 染色测定的梗死体积、神经元密度密切相关, 与神经症状综合评分具有等级相关。Pranlukast 和尼莫地平能减少脑梗死体积和脑半球的缺血侧/非缺血侧比值, 减轻神经症状和神经元死亡。结论:透光法结合神经症状综合评分法可用于小鼠局灶性脑缺血的定量分析和药物的神经保护作用评价。

Quantitative analysis of focal ischemic cerebral infarction in mice

AIM: To confirm the action of the light transmission method in evaluating focal ischemic cerebral infarction on persistent focal cerebral ischemia in mice. METHODS: Persistent focal cerebral ischemia was induced by middle cerebral artery occlusion (MCAO).Bederson's neurological scores, climbing board and hanging test were performed 24 h after ischemia, and infarct volume, brain hemisphere area, neuron density of cortex and subcortex were measured with computer-assisted imaging. Pranlukast (0.1 mg°kg^-1) or nimodipine (0.4 mg°kg^-1) were injected ip once daily for 3 days and to 1 h before MCAO assess the neuroprotective effect.RESULTS: The infarct volumes measured by light transmission closely correlated with that measured by TTC staining and neuron densities.The infarct volumes measured by light transmission well correlated with the neurological scores measured by integrated graded approach, too.Both pranlukast and nimodipine significantly attenuated infarct volumes and the ratio of ischemic/non-ischemic hemispheres, and reduced neurological deficits and neuron death. CONCLUSION: Light transmission and integrated graded approach can be used not only for qualitative analysis of focal cerebral ischemia, but also for evaluating the neuroprotective effect of drugs.